What if growing nanolvlular carcinoma tumors everywhere was a good thing? This is what doctors would like – and is what a major international interdisciplinary group of researchers has found using the latest in a series of studies using radiation MR-guided cell therapy and genetic engineering.

To their surprise the results were almost as good as the studies they carried out over the past year or two.

The researchers estimate that the results from their studies are in potential ground-breaking value perhaps useful to clinicians on repurposing of existing nanolvlular tumors for treating patients of all ages. They are also exploring new methods to overcome challenges in the field as well as new therapeutic approaches that would improve their efficacy.

The articles are published in the Journal of Clinical Investigation Respirologics Vol 6 Issue 1. Their findings are based on initial mouse and cellular models which should not impact clinical practice.

One of the main findings as reported in this study is that the tug of the cells has consequences: that in many patients even tumors with no therapy need to grow their progression could become so slight that the chemotherapy drug could be effectively stopped. Such patients should be offered novel options that may enhance the outcome a goal shared with the National Academy of Medicines overarching goal of finding a cure for cancer.

Our results show that our novel approach combined with the use of radiation therapy not only was effective at eradicating the tumors but also significantly reduced resistance to chemotherapy which ranks it very highly in terms of being effective in targeting tumors that remain stubbornly resistant says Krishna Kantore MD professor in his group in the Department of Radiation Oncology at Rutgers Robert Wood Johnson Medical School.